BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 17319458)

  • 1. Metabolic syndrome, inflammation and atherosclerosis.
    Paoletti R; Bolego C; Poli A; Cignarella A
    Vasc Health Risk Manag; 2006; 2(2):145-52. PubMed ID: 17319458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of the insulin resistance syndrome.
    Meigs JB
    Curr Diab Rep; 2003 Feb; 3(1):73-9. PubMed ID: 12643149
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome: demographic features, etiology, and clinical management.
    Wyne KL
    Curr Atheroscler Rep; 2005 Sep; 7(5):381-8. PubMed ID: 16105482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds.
    Grundy SM
    J Am Coll Cardiol; 2006 Mar; 47(6):1093-100. PubMed ID: 16545636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should the insulin resistance syndrome be treated in the elderly?
    Grant RW; Meigs JB
    Drugs Aging; 2004; 21(3):141-51. PubMed ID: 14979733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implications of the metabolic syndrome.
    Ceska R
    Diab Vasc Dis Res; 2007 Sep; 4 Suppl 3():S2-4. PubMed ID: 17935057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nurse health and lifestyle modification versus standard care in 40 to 70 year old regional adults: study protocol of the Management to Optimise Diabetes and mEtabolic syndrome Risk reduction via Nurse-led intervention (MODERN) randomized controlled trial.
    Carrington MJ; Zimmet P
    BMC Health Serv Res; 2017 Dec; 17(1):813. PubMed ID: 29212477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome: therapeutic considerations.
    Grundy SM
    Handb Exp Pharmacol; 2005; (170):107-33. PubMed ID: 16596797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Dyslipidemia in Patients with Hypertension, Diabetes, and Metabolic Syndrome.
    Srikanth S; Deedwania P
    Curr Hypertens Rep; 2016 Oct; 18(10):76. PubMed ID: 27730495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome: cardiovascular risk assessment and management.
    Wong ND
    Am J Cardiovasc Drugs; 2007; 7(4):259-72. PubMed ID: 17696567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolic syndrome: diagnosis and treatment.
    Zieve FJ
    Clin Cornerstone; 2004; 6 Suppl 3():S5-13. PubMed ID: 15707265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity, metabolic syndrome, and type 2 diabetes: inflammatory basis of glucose metabolic disorders.
    Pradhan A
    Nutr Rev; 2007 Dec; 65(12 Pt 2):S152-6. PubMed ID: 18240540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The expanding scope of the metabolic syndrome and implications for the management of cardiovascular risk in type 2 diabetes with particular focus on the emerging role of the thiazolidinediones.
    Greenberg AS
    J Diabetes Complications; 2003; 17(4):218-28. PubMed ID: 12810246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic syndrome and cardiovascular disease: Part I.
    Jiamsripong P; Mookadam M; Honda T; Khandheria BK; Mookadam F
    Prev Cardiol; 2008; 11(3):155-61. PubMed ID: 18607151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and diabetic atherothrombosis: implications in vascular complications.
    Meerarani P; Badimon JJ; Zias E; Fuster V; Moreno PR
    Curr Mol Med; 2006 Aug; 6(5):501-14. PubMed ID: 16918371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and Alzheimer's disease: a link to a vascular hypothesis?
    Milionis HJ; Florentin M; Giannopoulos S
    CNS Spectr; 2008 Jul; 13(7):606-13. PubMed ID: 18622365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pharmacological management of metabolic syndrome.
    Rask Larsen J; Dima L; Correll CU; Manu P
    Expert Rev Clin Pharmacol; 2018 Apr; 11(4):397-410. PubMed ID: 29345505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome.
    Vitale C; Marazzi G; Volterrani M; Aloisio A; Rosano G; Fini M
    Minerva Med; 2006 Jun; 97(3):219-29. PubMed ID: 16855517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological treatment and therapeutic perspectives of metabolic syndrome.
    Lim S; Eckel RH
    Rev Endocr Metab Disord; 2014 Dec; 15(4):329-41. PubMed ID: 25342235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Risk Atherosclerosis and Metabolic Phenotype: The Roles of Ectopic Adiposity, Atherogenic Dyslipidemia, and Inflammation.
    Lechner K; McKenzie AL; Kränkel N; Von Schacky C; Worm N; Nixdorff U; Lechner B; Scherr J; Weingärtner O; Krauss RM
    Metab Syndr Relat Disord; 2020 May; 18(4):176-185. PubMed ID: 32119801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.